Diacylglycerol Signaling

3 Phorbol Esters and Diacylglycerol: The PKC Activators
Gould, C. M., & Newton, A. C. (2008). The life and death of protein kinase C. Current Drug
Targets, 9, 614–625.
Grant, S., Turner, A. J., Freemerman, A. J., Wang, Z., Kramer, L., & Jarvis, W. D. (1996).
Modulation of protein kinase C activity and calcium-sensitive isoform expression in human
myeloid leukemia cells by bryostatin 1: Relationship to differentiation and Ara-C induced
apoptosis. Experimental Cell Research, 228, 65–75.
Griner, E. M., & Kazanietz, M. G. (2007). Protein kinase C and other diacylglycerol effectors in
cancer. Nature Reviews. Cancer, 7, 281–294.
Hecker, E. (1968). Cocarcinogenic principles from the seed oil of Croton tiglium and from other
Euphorbiaceae. Cancer Research, 28, 2338–2349.
Hecker, E. (1978). Structure-activity relationships in diterpene esters irritant and cocarcinogenic
to mouse skin. In T. J. Slaga, A. Sivak, & R. K. Boutwell (Eds.), Carcinogenesis (Vol. 2,
pp. 11–48). NY: Mechanisms of Tumor Promotion and Cocarcinogenesis Raven Press.
Hennings, H., Blumberg, P. M., Pettit, G. R., Herald, C. L., Shores, R., & Yuspa, S. H. (1987).
Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in
SENCAR mouse skin. Carcinogenesis, 8, 1343–1346.
Hennings, H., & Boutwell, R. K. (1970). Studies on the mechanism of skin tumor promotion.
Cancer Research, 30, 312–320.
Heo, J., Thapar, R., & Campbell, S. L. (2005). Recognition and activation of Rho GTPases by
Vav1 and Vav2 guanine nucleotide exchange factors. Biochemistry, 44, 6573–6585.
Hommel, U., Zurini, M., & Luyten, M. (1994). Solution structure of a cysteine rich domain of rat
protein kinase C. Nature Structural Biology, 1, 383–387.
Hornstein, I., Alcover, A., & Katzav, S. (2004). Vav proteins, masters of the world of cytoskeleton
organization. Cellular Signalling, 16, 1–11.
Hritz, J., Ulicny, J., Laaksonen, A., Jancura, D., & Miskovsky, P. (2004). Molecular interaction
model for the C1b domain of protein kinase C-g in the complex with its activator phorbol-12myristate-13-acetate
in water solution and lipid bilayer. Journal of Medicinal Chemistry, 47,
6547–6555.
Hurley, J. H., Newton, A. C., Parker, P. J., Blumberg, P. M., & Nishizuka, Y. (1997). Taxonomy
and function of C1 protein kinase C homology domains. Protein Science, 6, 477–480.
Ikuta, T., Chida, K., Tajima, O., Matsuura, Y., Iwamori, M., Ueda, Y., et al. (1994). Cholesterol
sulfate, a novel activator for the eta isoform of protein kinase C. Cell Growth Diff, 9,
943–947.
Irie, K., Masuda, A., Shindo, M., Nakagawa, Y., & Ohigashi, H. (2004a). Tumor promoter binding
of the protein kinase C C1 homology domain peptides of RasGRPs, chimaerins, and Unc13s.
Bioorganic & Medicinal Chemistry, 12, 4575–4583.
Irie, K., Nakagawa, Y., & Ohigashi, H. (2004b). Indolactam and benzolactams compounds as new
medicinal leads with binding selectivity for C1 domains of protein kinaseC isozymes. Current
Pharmaceutical Design, 10, 1371–1385.
Irie, K., Nakagawa, Y., & Ohigashi, H. (2005). Toward the development of new medicinal leads
with selectivity for protein kinase C isozymes. Chemical Record, 5, 185–195.
Itai, A., Kato, Y., Tomioka, N., Iitaka, Y., Endo, Y., Hasegawa, M., et al. (1988). A receptor model
for tumor promoters: Rational superposition of teleocidins and phorbol esters. Proceedings of
the National Academy of Sciences of the United States of America, 85, 3688–3692.
Johnson, J. E., Goulding, R. E., Ding, Z., Partovi, A., Anthony, K. V., Beaulieu, N., et al. (2007).
Differential membrane binding and diacylglycerol recognition by C1 domains of RasGRPs.
Biochemical Journal, 406, 223–236.
Kang, J. H., Benzaria, S., Sigano, D. M., Lewin, N. E., Pu, Y., Peach, M. L., et al. (2006).
Conformationally constrained analogues of diacylglycerol. 26. Exploring the chemical space
surrounding the C1 domain of protein kinase C with DAG-lactones containing aryl groups at
the sn-1 and sn-2 positions. Journal of Medicinal Chemistry, 49, 3185–3203.
Kang, J. H., Chung, H. E., Kim, S. Y., Kim, Y., Lee, J., Lewin, N. E., et al. (2003). Conformationally
constrained analogues of diacylglycerol (DAG). Effect on protein kinase C (PK-C) binding by
49